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ABSTRACT 
Many chemotherapeutic drugs have been used for the treatment of cancer, forinstance, 
doxorubicin, irinotecan, 5-fluorouracil, cisplatin, and paclitaxel. However, the effectiveness 
of chemotherapy is limited in cancer therapy due to drug resistance, therapeutic selectivity, 
and undesirable side effects. The combination of therapies with natural compounds is likely 
to increase the effectiveness of drug treatment as well as reduce the adverse outcomes. 
Curcumin, a polyphenolic isolated from Curcuma longa, belongs to the rhizome of 
Zingiberaceae plants. Studies from in vitro and in vivo revealed that curcumin exerts many 
pharmacological activities with less toxic effects. The biological mechanisms underlying the 
anticancer activity of co-treatment curcumin and chemotherapy are complex and worth to 
discuss further. Therefore, this review aimed to address the molecular mechanisms of 
combined curcumin and chemotherapy in the treatment of cancer. The anticancer activity of 
combined nanoformulation of curcumin and chemotherapy was also discussed in this study. 
Taken together, a better understanding of the implication and underlying mechanisms of 
action of combined curcumin and chemotherapy may provide a useful approach to combat 
cancer diseases. 
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